247 related articles for article (PubMed ID: 12472179)
1. Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals.
Klaamas K; Kurtenkov O; Rittenhouse-Olson K; Brjalin V; Miljukhina L; Shljapnikova L; Engstrand L
Immunol Invest; 2002; 31(3-4):191-204. PubMed ID: 12472179
[TBL] [Abstract][Full Text] [Related]
2. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
3. Association of Helicobacter pylori gastric infection with the suppressed Thomsen-Friedenreich antigen natural humoral response.
Kurtenkov O; Wadström T; Klaamas K; Vorobjova T; Uibo R
Scand J Gastroenterol; 1995 Feb; 30(2):116-21. PubMed ID: 7732332
[TBL] [Abstract][Full Text] [Related]
4. Better survival of Helicobacter pylori infected patients with early gastric cancer is related to a higher level of Thomsen-Friedenreich antigen-specific antibodies.
Kurtenkov O; Klaamas K; Sergeyev B; Chuzmarov V; Miljukhina L; Shljapnikova L
Immunol Invest; 2003 Feb; 32(1-2):83-93. PubMed ID: 12722944
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro.
Vollmers HP; Dämmrich J; Ribbert H; Grassel S; Debus S; Heesemannn J; Müller-Hermelink HK
Cancer; 1994 Sep; 74(5):1525-32. PubMed ID: 8062186
[TBL] [Abstract][Full Text] [Related]
6. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
7. Immune response to a recombinant fragment of the CagA protein of Helicobacter pylori in blood donors and patients with gastric cancer: relation to ABO(H) blood group phenotype, stage of the disease and tumor morphology.
Klaamas K; Kurtenkov O; Covacci A; Lipping A; Wadström T
Med Microbiol Immunol; 1999 May; 187(4):227-32. PubMed ID: 10363680
[TBL] [Abstract][Full Text] [Related]
8. Antigenic proteins of Helicobacter pylori of potential diagnostic value.
Khalilpour A; Santhanam A; Wei LC; Saadatnia G; Velusamy N; Osman S; Mohamad AM; Noordin R
Asian Pac J Cancer Prev; 2013; 14(3):1635-42. PubMed ID: 23679248
[TBL] [Abstract][Full Text] [Related]
9. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
[TBL] [Abstract][Full Text] [Related]
10. Production of monoclonal antibodies neutralizing vacuolation of cultured cells by Helicobacter pylori cytotoxin.
Yamaguchi H; Osaki T; Taguchi H; Kamiya S
FEMS Microbiol Lett; 1998 Nov; 168(2):277-82. PubMed ID: 9835039
[TBL] [Abstract][Full Text] [Related]
11. Seroreactivity to 19.5-kDa antigen in combination with absence of seroreactivity to 35-kDa antigen is associated with an increased risk of gastric adenocarcinoma.
Chua TS; Fock KM; Chan YH; Dhamodaran S; Sim CS; Ng TM; Teo EK
Helicobacter; 2002 Aug; 7(4):257-64. PubMed ID: 12165034
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients.
Hirai M; Azuma T; Ito S; Kato T; Kohli Y; Fujiki N
Int J Cancer; 1994 Jan; 56(1):56-60. PubMed ID: 8262677
[TBL] [Abstract][Full Text] [Related]
13. Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients.
Yan J; Mao YF; Shao ZX
World J Gastroenterol; 2005 Jan; 11(3):421-5. PubMed ID: 15637759
[TBL] [Abstract][Full Text] [Related]
14. Low antigenicity of the polysaccharide region of Helicobacter pylori lipopolysaccharides derived from tumors of patients with gastric cancer.
Yokota S; Amano K; Hayashi S; Fujii N
Infect Immun; 1997 Sep; 65(9):3509-12. PubMed ID: 9284113
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori heat shock protein 60 antibodies are associated with gastric cancer.
Tanaka A; Kamada T; Yokota K; Shiotani A; Hata J; Oguma K; Haruma K
Pathol Res Pract; 2009; 205(10):690-4. PubMed ID: 19450936
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori in gastric cancer and peptic ulcer disease in a Colombian population. Strain heterogeneity and antibody profiles.
Piñeros DM; Riveros SC; Marin JD; Ricardo O; Díaz OO
Helicobacter; 2001 Sep; 6(3):199-206. PubMed ID: 11683922
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to Helicobacter pylori excretory antigen and the cross reaction study.
Sasidharan S; Uyub AM
J Immunoassay Immunochem; 2009; 30(1):70-81. PubMed ID: 19117203
[TBL] [Abstract][Full Text] [Related]
18. Serum antibody response to the superficial and released components of Helicobacter pylori.
Bazillou M; Fendri C; Castel O; Ingrand P; Fauchére JL
Clin Diagn Lab Immunol; 1994 May; 1(3):310-7. PubMed ID: 7496968
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori recombinant UreG protein: cloning, expression, and assessment of its seroreactivity.
Khalilpour A; Osman S; Yunus MH; Santhanam A; Vellasamy N; Noordin R
BMC Res Notes; 2014 Nov; 7():809. PubMed ID: 25406411
[TBL] [Abstract][Full Text] [Related]
20. A coordinated cytotoxic effect of IFN-gamma and cross-reactive antibodies in the pathogenesis of Helicobacter pylori gastritis.
Itoh T; Yoshida M; Chiba T; Kita T; Wakatsuki Y
Helicobacter; 2003 Aug; 8(4):268-78. PubMed ID: 12950599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
